Metabolomics Services Market Size, Share and Growth Analysis


Posted October 21, 2019 by venkatapbi

The Global Metabolomics Services Market is expected to reach US$ 4,135.3 Mn by 2025 owing to increasing prevalence of life threatening diseases
 
Metabolomics Services Market Size and Growth Rate:

“The Global Metabolomics Services Market is expected to reach US$ 4,135.3 Mn by 2025 owing to increasing prevalence of life threatening diseases”

Metabolomics Services Market Growth Drivers and Restraints:

The global metabolomics services market is expected to reach US$ 4,135.3 Mn by 2025. Metabolomics is the scientific study of chemical processes involving metabolites, the small molecule substrates, intermediates and products of metabolism. The factors which are driving the growth of global metabolomics services market are growing demand for personalized medicines, technological advancements, and increasing use of metabolomics in toxicology testing. Furthermore, integration of the metabolomics data into the clinical workflows helps in understanding the profile of the persons and plays a major role in personalized treatment of that person. The data also helps in detecting various diseases like cancer, genetic disorders, and cardiovascular diseases etc. Additionally, increasing research and development in pharmaceutical and biotechnological department, and availability of government and private funding are surging the growth of global metabolomics services market. On the other hand high cost of tools and instruments, and growing issues related to data examination and processing are hampering the growth of global metabolomics services market.

Browse More Insights of the report @ https://www.precisionbusinessinsights.com/market-reports/global-metabolomics-services-market/

Tumor Dominate the Global Metabolomics Services Market

Based on the sample type, global metabolomics services market is segmented into urine, tumor, cell culture media, whole blood, food ingredients, and feces. Tumor dominates the global metabolomics services market owing to increasing prevalence of cancers globally. The abnormal cell growth in later phase leads to cancer. According to WHO cancer is a leading cause of death globally, accounting for an estimated 9.6 million deaths in 2018. So detection of cancer in early stages through metabolomics will stream the growth of global metabolomics services market in the forecast period.

North America Leads the Global Metabolomics Services Market

PBI’s global metabolomics services market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the global metabolomics services market through 2014-2018 and expected to dominate over 2019-2025 owing to increase in demand for personalized medicines, improved healthcare facility, presence of major market players, and technological development. Furthermore, growing research and development and increasing government funding are propelling the growth of metabolomics services market in North America. Europe metabolomics services market accounted for a significant share in global metabolomics services market due to their high prevalence of cancer and cardiovascular diseases in European population and increasing research and developmental activities in the field if metabolomics. Moreover, development in healthcare infrastructure, and increase in disposable income in countries such as UK, Germany etc. are also streaming the market growth in Europe region. Asia Pacific metabolomics services market expected to grow significant rate owing to the increased demand for biomarkers, for the diagnosis of various life threatening diseases and rising awareness about various metabolomic technologies in the emerging countries such as China and India are surging the growth of metabolomics services market in APAC region.
Launch of newer services, and strategic alliances are the key strategies adopted by market players

Global metabolomics services market further reveals that the key player’s increasingly adopting strategies such as launch of newer treatment therapies, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.
 For instance, in September 2017, Metabolon, Inc., acquired Metabolomic Discoveries GmbH to increase the sale of the products around the globe.

Key player’s profiles in the report are Lipotype GmbH (Germany), Metanomics Health GmbH (Germany), Metabolon, Inc. (USA), Metabolomic Discoveries GmbH (Germany), OWL Metabolomics (Spain), Creative Untargeted Metabolite Assay (USA), Stemina Biomarker Discovery, Inc (USA), Chenomx Inc.(Canada), TMIC (Canada), and West Coast Metabolomics center (USA).

Avail Sample of the report for more information @ https://www.precisionbusinessinsights.com/request-sample?product_id=16500

Detailed Segmentation of Metabolomics Services Market:

By Service Type
• Separation & Detection Services
• Lipidomics
• Untargeted Metabolite Assay
• Targeted Metabolite Assays
• Bioinformatics Services

By Sample Type
• Urine
• Tumor
• Cell Culture Media
• Whole Blood
• Food Ingredients
• Feces

By Sample Source
• Human
• Animal
• Others

End User
• Healthcare Industry
• Academic & Research Institutes
• Food Processing Industry
• Others

Geography

o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Precision Business Insights
Country India
Categories Health
Tags metabolomics services market
Last Updated October 21, 2019